HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hendrickson, F. R. Search for Related Content PubMed PubMed Citation Articles by Hendrickson, F. R.

CA: A Cancer Journal for Clinicians, Vol 38, 353-361, Copyright © 1988 by American Cancer Society

The Use of Neutron Beam Therapy In the Management of Locally Advanced Nonresectable Radioresistant Tumors

¹ Principal Investigator at the Midwest Institute for Neutron Therapy at Fermilab in Batavia, Illinois.

Locally advanced nonresectable radioresistant tumors can often be ablated by external irradiation using high-energy fast neutrons. Long-term remission, with local control rates of 50 to 70 percent, have been reported in a number of very large osteogenic sarcomas, soft tissue sarcomas, melanomas, and adenocarcinomas of the alimentary tract. Malignant salivary gland tumors and prostate carcinomas respond well to neutron therapy, with high remission rates and significantly increased survival, even in locally advanced stages of the disease. Neutron beam therapy is a valuable adjunct in the management of nonresectable cancers that are resistant to conventional therapy.